World's Best Scientists 2026 revealed!

D-Index & Metrics

Social Sciences and Humanities

D-Index
65
Citations
16088
World Ranking
1035
National Ranking
198

Overview

Linda Davies is affiliated with the University of Manchester in the United Kingdom. Their research spans the fields of Medicine and Psychology, focusing particularly on General Health Professions, Clinical Psychology, Psychiatry and Mental Health, Economics and Econometrics, and Cardiology and Cardiovascular Medicine.

Their work covers several main topics including:

  • Schizophrenia research and treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Health and Mental Health
  • Autism Spectrum Disorder Research
  • Stroke Rehabilitation and Recovery
  • Geriatric Care and Nursing Homes
  • Family and Disability Support Research

Linda Davies has contributed publications to various frequent venues such as:

  • Programme Grants for Applied Research
  • BMJ Open
  • Health Technology Assessment
  • Value in Health
  • The Lancet Oncology

Among recent papers, they have been involved in the following publications:

  • Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial, 2021, The Lancet Oncology
  • What is important to people with dementia living at home? A set of core outcome items for use in the evaluation of non-pharmacological community-based health and social care interventions, 2020, Age and Ageing
  • Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY-A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy, 2021, Circulation
  • Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study, 2020, The Lancet Psychiatry
  • Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency, 2021, PharmacoEconomics

Frequent co-authors who have collaborated extensively with Linda Davies include:

  • Gemma Shields
  • David Reeves
  • Adrian Wells
  • Lora Capobianco
  • Patrick Doherty

Best Publications

  • Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)

    Peter B. Jones;Thomas R. E. Barnes;Linda Davies;Graham Dunn

  • Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

    Angela Lamarca;Daniel H Palmer;Harpreet Singh Wasan;Paul J Ross

  • Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

    Shôn Lewis;Nicholas Tarrier;Gillian Haddock;Richard Bentall

  • Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

    Shôn W. Lewis;Thomas R. E. Barnes;Linda Davies;Robin M. Murray

  • Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

    Michael F. Drummond;Linda Davies

  • Generalisability in economic evaluation studies in healthcare: a review and case studies.

    Sculpher Mj;Pang Fs;Manca A;Drummond Mf

  • Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial

    Anthonty P. Morrison;Paul French;Suzanne L.K. Stewart;Max Birchwood

  • Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.

    J Bamford;H Fortnum;K Bristow;J Smith

  • Patient empowerment: The need to consider it as a measurable patient-reported outcome for chronic conditions

    Marion McAllister;Graham Dunn;Katherine Payne;Linda Davies

  • Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial

    Anthony P Morrison;Anthony P Morrison;Douglas Turkington;Douglas Turkington;Melissa Pyle;Melissa Pyle;Helen Spencer;Helen Spencer

  • Cognitive-behavioural therapy in first-episode and early schizophrenia: 18-month follow-up of a randomised controlled trial

    Nicholas Tarrier;Shôn Lewis;Gillian Haddock;Richard Bentall

  • Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

    Sarah Lewis;L Davies;Pamela Jones;T R E Barnes

  • Cost-effectiveness of cardiac rehabilitation: a systematic review

    Gemma E Shields;Adrian Wells;Patrick Doherty;Anthony Heagerty

  • Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial

    Christine Barrowclough;Gillian Haddock;Til Wykes;Ruth Beardmore

  • Economics and schizophrenia: the real cost.

    Linda M. Davies;Michael F. Drummond

  • ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.

    Angela Lamarca;Daniel H. Palmer;Harpreet Singh Wasan;Paul J. Ross

  • Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.

    Gillian Haddock;Christine Barrowclough;Nicholas Tarrier;Jan Moring

  • The economic burden of schizophrenia

    Linda M. Davies;Michael F. Drummond

  • Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: a randomised controlled trial

    Audrey Bowen;Anne Hesketh;Emma Patchick;Alys Young

  • Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.

    L Davies;TJ Brown;S Haynes;K Payne

Frequent Co-Authors

Michael Drummond
Michael Drummond University of York
Anthony P. Morrison
Anthony P. Morrison University of Manchester
David Challis
David Challis University of Nottingham
Nicholas Tarrier
Nicholas Tarrier University of Manchester
Dian Donnai
Dian Donnai University of Manchester
Max Birchwood
Max Birchwood University of Warwick
Richard Morriss
Richard Morriss University of Nottingham
Til Wykes
Til Wykes King's College London
Deborah P. M. Symmons
Deborah P. M. Symmons University of Manchester
John Keady
John Keady University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering studying Social Sciences and Humanities in the USA, there are flexible online degree pathways to help elevate your career. Many students pursue an online masters degree psychology to build foundational knowledge for roles in counseling, research, and education. Online programs allow for study alongside work or family commitments.

Those aiming for advanced clinical roles often consider accredited psyd programs. These programs train future psychologists with a focus on hands-on practice and licensure preparation. Another promising track is in marriage and family therapy. Students seeking accelerated options can benefit from marriage and family therapy online programs that help professionals enter this growing field faster.

If your interests align with leadership and education, an online doctorate of education programs can help you achieve top qualifications for academic, administrative, or policy roles. Each of these paths has unique admission requirements, career outcomes, and time commitments—do your research to find the best fit for your goals.

Best Scientists Citing Linda Davies

Trending Scientists